Rosiglitazone-Metformin Combination Versus Metformin-Sulfonylurea Combination On Beta-Cell Function In Type 2 Diabetes

NCT00367055 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: rosiglitazone-metformin
DRUG: Metformin
DRUG: metformin+ gliclazide

Sponsor

GlaxoSmithKline